Related Experiment Video
Updated: Jun 16, 2025
Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
Published on: February 8, 2017
Tumor Microenvironment in Melanoma Brain Metastasis: A New Potential Target?
Gerardo Caruso1, Cristofer Gonzalo Garcia Moreira1, Edvige Iaboni1
1Unit of Neurosurgery, Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, 98125 Messina, Italy.
Abstract:
Melanoma, a malignant skin tumor, is the third skin tumor and the third cause of brain metastases. The development and introduction of systemic therapies, such as Braf inhibitors and checkpoint inhibitors, have guaranteed an increase in overall survival. The appearance of brain metastases, which determines a median survival of less than 5 months, represents a sign of systemic disease progression and tumor instability. In this view, in addition to systemic therapy, the therapeutic options can be surgery, stereotactic surgery, and whole-brain radiation therapy. However, it has been observed that the response to systemic therapies of brain metastatic lesions, compared to extracerebral ones, does not guarantee complete local tumor control, thus increasing the mortality and morbidity of patients. This phenomenon, tumor escape, makes systemic therapy partly ineffective. How melanoma cells migrate, cross the blood-brain barrier, and invade brain tissue is still being studied. The melanocytic metastatic brain tumor microenvironment and its assay seem to have a key role in the response and therefore in the progression of metastatic lesions. Through this work, the intent is to underline the importance of the brain tumor microenvironment and how it can influence tumor growth, its response to therapy, and the patient's overall survival.
Insights
Brain metastases from melanoma are a significant challenge, often resisting systemic therapies. Understanding the brain tumor microenvironment is crucial for improving melanoma treatment outcomes and patient survival.
Area of Science:
- Oncology
- Neuroscience
- Dermatology
Background:
- Melanoma is a significant cause of brain metastases, impacting patient survival.
- Systemic therapies like BRAF and checkpoint inhibitors have improved overall survival but brain metastases remain a challenge.
- Brain metastases signify disease progression and reduced median survival, necessitating multimodal treatment approaches.
Purpose of the Study:
- To highlight the critical role of the brain tumor microenvironment in melanoma brain metastasis.
- To investigate how the tumor microenvironment influences therapeutic response and patient survival.
- To understand the mechanisms of melanoma cell invasion across the blood-brain barrier.
Main Methods:
- Review of current understanding of melanoma brain metastasis.
- Analysis of the impact of systemic therapies on brain lesions versus extracerebral lesions.
- Exploration of the role of the tumor microenvironment in therapeutic resistance.
Main Results:
- Systemic therapies show limited efficacy in controlling brain metastatic lesions compared to extracerebral ones.
- Melanoma cells' ability to cross the blood-brain barrier and invade brain tissue is under investigation.
- The tumor microenvironment appears to play a key role in treatment response and metastatic lesion progression.
Conclusions:
- The brain tumor microenvironment significantly influences melanoma brain metastasis growth and response to therapy.
- Understanding the tumor microenvironment is essential for overcoming therapeutic resistance and improving patient survival.
- Further research into the tumor microenvironment is needed to develop more effective treatments for melanoma brain metastases.
Related Concept Videos
02:17The Tumor Microenvironment
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...